stella
beta
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop — Stella
Home
/
Chronic Liver Disease
/
View on ClinicalTrials.gov
Recruiting
Back to Chronic Liver Disease trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
South Korea
GC wellbeing, Yongin-si